Drug Profile
XRx 117
Alternative Names: XRx-117Latest Information Update: 28 May 2022
Price :
$50
*
At a glance
- Originator XORTX Therapeutics
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Non-alcoholic steatohepatitis
Most Recent Events
- 28 May 2022 No recent reports of development identified for preclinical development in Non-alcoholic-steatohepatitis in Canada
- 10 Apr 2018 Preclinical trials in Non-alcoholic steatohepatitis in Canada (unspecified route) before April 2018 (Xortx Therapeutics pipeline, April 2018)